Salloum, E <br/><br/>
Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.  [electronic resource] 

 -  The cancer journal from Scientific American   
 - 267-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1081-4442 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--therapeutic use<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Dacarbazine--therapeutic use<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Male<br/>Mechlorethamine--therapeutic use<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasms, Second Primary--drug therapy<br/>Prednisone--therapeutic use<br/>Procarbazine--therapeutic use<br/>Remission Induction<br/>Salvage Therapy<br/>Time Factors<br/>Treatment Outcome<br/>Vinblastine--therapeutic use<br/>Vincristine--therapeutic use